Literature DB >> 16758224

[Skin tumors in organ-transplant recipients].

D Nashan1, P Radny, N C Kösters, B Nashan.   

Abstract

Skin cancers are a significant medical problem for organ-transplant recipients. Squamous cell carcinoma and basal cell carcinoma are most common tumors. An increasing incidence of melanoma, Kaposi sarcoma, Merkel cell carcinoma, as well as uncommon skin malignancies, is also seen. Predisposing factors include cumulative sun exposure, cumulative immunosuppression, age, gender, skin type, virus detection and genetic alterations. Skin tumors grow rapidly and their number continues to increase in the years following transplantation. Large numbers of tumors, aggressive courses and appearance in young patients are other characteristics of these skin tumors. More general awareness of the need for preventive measures and regular dermatological examinations is desirable. In addition standardized registries are needed to assure the comparability of data, to better correlate immunosuppression with skin tumors and to plan therapeutic studies.

Entities:  

Mesh:

Year:  2007        PMID: 16758224     DOI: 10.1007/s00105-006-1159-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Cutaneous neoplasm and its relationship with factors due to renal transplant.

Authors:  B Bayés; R Lauzurica; M J Fuente; J Bonet; M Ribera; R Romero; C Ferrandiz
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

2.  Skin cancer after renal transplantation: the causal role of azathioprine.

Authors:  A E Taylor; S Shuster
Journal:  Acta Derm Venereol       Date:  1992       Impact factor: 4.437

3.  Skin cancer's ranks rise: immunosuppression to blame.

Authors:  Tracy Hampton
Journal:  JAMA       Date:  2005-09-28       Impact factor: 56.272

4.  Cancers in cyclosporine-treated vs azathioprine-treated patients.

Authors:  I Penn
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

5.  Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.

Authors:  C Hiesse; J R Larue; F Kriaa; P Blanchet; J Bellamy; G Benoit; B Charpentier
Journal:  Transplant Proc       Date:  1995-08       Impact factor: 1.066

6.  Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.

Authors:  A L Caforio; A B Fortina; S Piaserico; M Alaibac; F Tona; G Feltrin; E Pompei; L Testolin; A Gambino; S D Volta; G Thiene; D Casarotto; A Peserico
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

7.  Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients.

Authors:  Fergal J Moloney; Esmaeel Almarzouqi; Patrick O'Kelly; Peter Conlon; Gillian M Murphy
Journal:  Arch Dermatol       Date:  2005-08

8.  Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients.

Authors:  J N Bavinck; A De Boer; B J Vermeer; M M Hartevelt; F J van der Woude; F H Claas; R Wolterbeek; J P Vandenbroucke
Journal:  Br J Dermatol       Date:  1993-09       Impact factor: 9.302

9.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

Authors:  B Nashan; R Moore; P Amlot; A G Schmidt; K Abeywickrama; J P Soulillou
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

10.  Azathioprine and UVA light generate mutagenic oxidative DNA damage.

Authors:  Peter O'Donovan; Conal M Perrett; Xiaohong Zhang; Beatriz Montaner; Yao-Zhong Xu; Catherine A Harwood; Jane M McGregor; Susan L Walker; Fumio Hanaoka; Peter Karran
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.